Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,249 | -55,505 | -251,122 | -200,471 | -134,637 |
| Depreciation Amortization | 3,329 | 1,637 | 7,007 | 5,422 | 3,642 |
| Accounts receivable | -4,638 | 670 | -3,467 | -227 | -4,014 |
| Accounts payable and accrued liabilities | -5,265 | -2,566 | 84 | -308 | -2,886 |
| Other Working Capital | -35,152 | -9,591 | -156 | 3,267 | -15,951 |
| Other Operating Activity | 18,977 | 6,165 | 20,801 | 17,430 | 21,600 |
| Operating Cash Flow | $-113,998 | $-59,190 | $-226,853 | $-174,887 | $-132,246 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,532 | -44,178 | 125,968 | 107,686 | 40,880 |
| PPE Investments | -10 | -10 | -486 | -387 | -221 |
| Investing Cash Flow | $4,522 | $-44,188 | $125,482 | $107,299 | $40,659 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 82,648 | 82,648 | 31,800 | 24,107 | 3,641 |
| Other Financing Activity | -442 | -185 | -308 | -217 | -105 |
| Financing Cash Flow | $82,206 | $82,463 | $31,492 | $23,890 | $3,536 |
| Beginning Cash Position | 99,845 | 99,845 | 169,724 | 169,724 | 169,724 |
| End Cash Position | 72,575 | 78,930 | 99,845 | 126,026 | 81,673 |
| Net Cash Flow | $-27,270 | $-20,915 | $-69,879 | $-43,698 | $-88,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,998 | -59,190 | -226,853 | -174,887 | -132,246 |
| Capital Expenditure | -10 | -10 | -486 | -387 | -221 |
| Free Cash Flow | -114,008 | -59,200 | -227,339 | -175,274 | -132,467 |